Canadian radiation oncology ripe for AI education

Only 19 of 159 radiation oncology professionals working across Canada, or 12%, feel they’re well-versed in AI. However, more than 90% are open to learning its ways.

The survey behind the findings was commissioned and analyzed by Ewa Szumacher, MD, MEd, and colleagues at Sunnybrook Health Sciences Centre in Toronto. Their report is posted in the Journal of Medical Imaging and Radiation Sciences.

Along with radiation oncologists, respondents included radiation physicists, therapists and trainees. All 10 provinces had participants.

Other interesting findings from the responses:

  • 80% of respondents believe AI can save on time.
  • 62% think it can help improve patient outcomes.
  • 57% are concerned about AI having negative economic effects, including job losses.
  • 37% worry about its impact on patient interactions.

Further, radiation oncology professionals tend to believe AI will “be an important part of patient treatment in their future practices,” the authors report.

In their discussion section, Szumacher et al. comment:

“It is human nature to fear the unknown, and … multiple studies conducted internationally … are evidence of this. To eliminate the fear is to invest in educating professionals to know the importance and potential that AI can have on the future of treatment. In addition, it is important to work as a team with AI experts, researchers, software companies, radiation oncologists, radiation therapists, radiation physicists and radiation trainees, to grow this technology in the right direction.”

Dave Pearson

Dave P. has worked in journalism, marketing and public relations for more than 30 years, frequently concentrating on hospitals, healthcare technology and Catholic communications. He has also specialized in fundraising communications, ghostwriting for CEOs of local, national and global charities, nonprofits and foundations.

Around the web

Compensation for heart specialists continues to climb. What does this say about cardiology as a whole? Could private equity's rising influence bring about change? We spoke to MedAxiom CEO Jerry Blackwell, MD, MBA, a veteran cardiologist himself, to learn more.

The American College of Cardiology has shared its perspective on new CMS payment policies, highlighting revenue concerns while providing key details for cardiologists and other cardiology professionals. 

As debate simmers over how best to regulate AI, experts continue to offer guidance on where to start, how to proceed and what to emphasize. A new resource models its recommendations on what its authors call the “SETO Loop.”